
About ASolution Pharmaceuticals
ASolution Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 2010 by Nandkumar Chodankar. It provides API manufacturing, pharmaceutical development, and clinical supply services in India. It operates on a B2B model. ASolution Pharmaceuticals has raised $4.55 million across 1 funding round. The company has 119 employees. Its chief executive, as recorded, is Nandkumar Chodankar. Its Indian entity Asolution Pharmaceuticals Private Limited reported revenue of βΉ32.73 Cr. ASolution Pharmaceuticals offers products and services including API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development. Its focus areas include Healthcare and Life Sciences, Pharmaceuticals, Formulation Development and Clinical Supply. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
ASolution Pharmaceuticals, founded in 2010, is an Indian company led by experienced professionals. It specializes in cost-efficient CGMP services for APIs, finished formulations, and specialty molecules, covering synthetic chemistry, analytical development, and formulation. Based in Mumbai and Ambernath, it serves from early development to commercial manufacturing, holding certifications like US FDA and WHO GMP for global clients.
- Headquarters Mumbai, India
- Employees 119
- Founders Nandkumar Chodankar
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website asolution.in
- Legal Name Asolution Pharmaceuticals Private Limited
- Date of Incorporation 07 May, 2010
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹32.73 Cr
FY 2024 · +11% YoY
- Net Loss-₹8.58 Cr
FY 2024 · -26% margin
- EBITDA-₹15.4 Lakh
FY 2024 · 0% margin
- Total Equity Funding$4.55M (USD)
in 1 rounds
- Latest Funding Round$4.55M (USD), Series A
Feb 2011
- Employee Count119
Associated legal entities of ASolution Pharmaceuticals
ASolution Pharmaceuticals operates through Asolution Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Asolution Pharmaceuticals Private Limited CIN U24100MH2010PTC202851 | Active | 07 May 2010 | Mumbai, Maharashtra | ₹32.7 Cr | 119 | 2 | View details |
Products & Services of ASolution Pharmaceuticals
ASolution Pharmaceuticals offers a comprehensive portfolio of products and services, including API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development.
Develops and manufactures active pharmaceutical ingredients under CGMP standards.
Provides services for creating finished pharmaceutical formulations.
Offers chemical synthesis for pharmaceutical applications.
Conducts analytical testing for drug development processes.
Funding Insights of ASolution Pharmaceuticals
ASolution Pharmaceuticals has successfully raised a total of $4.55M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.55 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.55M
- Total Rounds 1
- Last Round Series A β $4.55M
- First Round $4.55M
(Feb 2011)
All 1 funding rounds of ASolution Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2011 | $4.55M | Series A | β | β | β |
Board of directors of Asolution Pharmaceuticals Private Limited (ASolution Pharmaceuticals)
Asolution Pharmaceuticals Private Limited is the primary company behind ASolution Pharmaceuticals. The board of Asolution Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Nandkumar Kashinath Chodankar, appointed in 2010.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nandkumar Kashinath Chodankar DIN 02736718 | Director | 07 May 2010 | 16 yrs 6 mo | Asolution Pharmaceuticals Private Limited |
| Laxmi Nandkumar Chodankar DIN 02868705 | Director | 07 May 2010 | 16 yrs 6 mo | Asolution Pharmaceuticals Private Limited |
People of ASolution Pharmaceuticals
1 people are tracked at ASolution Pharmaceuticals (1 in leadership); the tracked headcount is 119.
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership |
Complete people profiles for ASolution Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ASolution Pharmaceuticals
Figures of Asolution Pharmaceuticals Private Limited, the primary company behind ASolution Pharmaceuticals, for FY 2024. Revenue was ₹32.73 Cr (+11% year on year). Net loss was -₹8.58 Cr (-26% margin). EBITDA was -₹15.4 Lakh (0% margin). Revenue has grown at a compounded annual rate of +20% over three years and +13% over five years.
- ₹32.73 CrRevenue · FY 2024 · +11% YoY
- -₹8.58 CrNet loss · -26% margin
- -₹15.4 LakhEBITDA · 0% margin
- ₹4.89 CrPaid-up capital
- 119Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Asolution Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for ASolution Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of ASolution Pharmaceuticals
2 dated milestones of ASolution Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded ASolution Pharmaceuticals is founded.
- Funding First funding round of $4.5M.
Competitors of ASolution Pharmaceuticals
ASolution Pharmaceuticals has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of ASolution Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ASolution Pharmaceuticals
ASolution Pharmaceuticals was founded in 2010 and raised its 1st funding round 1 year after it was founded.
ASolution Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Nandkumar Chodankar is the CEO of ASolution Pharmaceuticals, as recorded in our data. They have also founded this company.
ASolution Pharmaceuticals is a funded company, having raised a total of $4.55M across 1 funding round to date. The company's 1st funding round was a Series A of $4.55M, raised on Feb 2011.
ASolution Pharmaceuticals has 119 employees.
The primary company behind ASolution Pharmaceuticals, Asolution Pharmaceuticals Private Limited, reported revenue of βΉ32.73 Cr for FY 2024, up 11% year on year.
ASolution Pharmaceuticals, founded in 2010, is an Indian company led by experienced professionals. It specializes in cost-efficient CGMP services for APIs, finished formulations, and specialty molecules, covering synthetic chemistry, analytical development, and formulation. Based in Mumbai and Ambernath, it serves from early development to commercial manufacturing, holding certifications like US FDA and WHO GMP for global clients.
ASolution Pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
ASolution Pharmaceuticals offers API Manufacturing, Formulation Development, Synthetic Chemistry, and Analytical Development.
ASolution Pharmaceuticals operates through Asolution Pharmaceuticals Private Limited.
The legal entities of ASolution Pharmaceuticals currently have 2 directors, including Nandkumar Kashinath Chodankar, Laxmi Nandkumar Chodankar.